On-Demand Webinar: Characterizing CAR-T Cells with Live-Cell Analysis and High-Throughput Screening
Duration: 33 minutes
Overview
The development of gene-modified cell therapies, particularly CAR-T cells, has transformed cancer treatment by offering personalized and potentially curative options. This webinar explores the integration of live-cell analysis and high-throughput screening (HTS) by cytometry to enhance the characterization of CAR-T cells.
Topics include the functional characterization of CAR-T cells, addressing "on target, off tumor" effects, and optimizing CAR-T expansion processes. Through detailed case studies, the webinar illustrates how these advanced techniques provide dynamic insights into CAR-T cell behavior, tools for characterization, and optimize expansion conditions.
Key Takeaways
- Functional characterization of CAR-T cells
- Solutions for addressing "on target, off tumor" effects
- Techniques for optimizing CAR-T expansion including gaining dynamic insights into CAR-T cell behavior, tools for characterization, and methods for optimizing expansion conditions
Webinar Speaker
Nicola Bevan
Manager of Application Development
European BioAnalytics Application Development
Sartorius
Nicola Bevan is a Manager of Application Development within the European BioAnalytics Application Development team at Sartorius. She is actively involved in the research and development of novel reagents and applications, enhancing the capabilities of life science instruments such as the Incucyte® live-cell analysis system and the iQue® HTS cytometer.
With over 30 years of experience, Nicola is a highly skilled cellular pharmacologist. She has an extensive background in the Pharmaceutical and Biotech industries, where she has gained broad experience in large pharma industrial screening departments and the support of early drug discovery programs.